提交至《英国医学杂志》的临床试验中非前瞻性注册的分析:观察性研究
结果显示较大样本量、大洋洲通讯作者、更多作者数、提及CONSORT、较近期投稿及有资助与降低非前瞻性注册几率相关,而亚洲通讯作者则与升高几率相关。176篇未前瞻性注册试验中83%为回顾性注册,多数随后发表于声称遵循ICMJE推荐的高影响因子期刊,仅约六分之一明确披露注册缺陷。
要点
- 样本量101-500对比1-100的OR为0.43(95%CI 0.22-0.84),与非前瞻性注册几率降低相关。
- 亚洲通讯作者对比欧洲的OR为1.75(95%CI 1.07-2.89),与非前瞻性注册几率升高相关。
- 176篇非前瞻性注册试验中146篇(83%)为回顾性注册,中位延迟193天。
核心结论
- 许多因非前瞻性注册被《英国医学杂志》拒稿的试验后来发表于声称遵循ICMJE推荐的高影响因子期刊,且常未披露注册缺陷。
主要发现
- 较大样本量(101-500对比1-100)与非前瞻性注册几率降低相关(OR 0.43,95%CI 0.22-0.84)。
- 大洋洲通讯作者对比欧洲与非前瞻性注册几率降低相关(OR 0.35,95%CI 0.14-0.82),亚洲通讯作者对比欧洲则与几率升高相关(OR 1.75,95%CI 1.07-2.89)。
- 更多作者数(10对比5,OR 0.71,95%CI 0.59-0.87)、提及CONSORT(OR 0.22,95%CI 0.06-0.67)、较近期投稿(2021-23对比2019-20,OR 0.63,95%CI 0.42-0.95)及有资助(非营利资助对比无资助或无信息,OR 0.20,95%CI 0.09-0.41)均与非前瞻性注册几率降低相关。
- 2019至2021年提交的176篇未在ICMJE认可注册中心前瞻性注册的试验中,146篇(83%)为回顾性注册(中位延迟193天),23篇(13%)未注册,7篇(4%)在非ICMJE认可注册中心注册。
- 155篇试验(88%)随后发表,其中138篇(89%)发表于有影响因子的期刊(中位影响因子5.39),96篇(62%)发表于声称遵循ICMJE推荐的期刊;从初次投稿至发表的中位时间为12个月,仅约六分之一在发表时明确披露注册缺陷。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To identify variables associated with non-prospective registration of clinical trials submitted to The BMJ; examine deficiencies in registration, disclosure of deficiencies, and subsequent publication status of such trials; and assess the authors' claims of prospective registration. DESIGN: Observational study. SETTING: The BMJ, London. POPULATION: 239 of 287 submissions to The BMJ (2019-23) reporting clinical trial results as defined by the International Committee of Medical Journal Editors (ICMJE) and flagged by editors as potentially not prospectively registered, and 239 trials prospectively registered in an ICJME accepted registry from a randomised list of all clinical trial submissions in the same period. MAIN OUTCOME MEASURES: Study outcomes included non-prospective registration in an ICJME accepted registry and, for non-prospectively registered trials, deficiencies in registration deficiencies in registration (retrospective in an ICJME accepted registry, registration in a non-ICJME accepted registry, or no registration), delay in registration of retrospectively registered trials, and subsequent publication status. Time to publication and disclosure of registration deficiencies on publication were also assessed, along with the journal's impact factor and whether the journal claimed adherence to the ICMJE registration recommendations. RESULTS: Reduced odds of non-prospective registration in an ICMJE accepted registry were associated with larger sample sizes (101-500 v 1-100; odds ratio 0.43, 95% confidence interval 0.22 to 0.84), corresponding authors from Oceania (reference: Europe; 0.35, 0.14 to 0.82), a greater number of authors (10 v 5; 0.71, 0.59 to 0.87), mention of Consolidated Standards Of Reporting Trials (0.22, 0.06 to 0.67), more recent submissions (2021-23 v 2019-20; 0.63, 0.42 to 0.95), and presence of funding (eg, non-profit v no funding or no information; 0.20, 0.09 to 0.41). Higher odds were observed for corresponding authors based in Asia (reference: Europe; 1.75, 1.07 to 2.89). Of 176 trials not prospectively registered in an ICMJE accepted registry submitted between 2019 and 2021, 146 (83%) were retrospectively registered (median delay 193 days), 23 (13%) were unregistered, and seven (4%) were registered in a non-ICJME accepted registry. Most (155 trials, 88%) were subsequently published; 138 (89%) of these appeared in journals with an impact factor (median 5.39) and 96 (62%) in journals claiming adherence to the ICMJE recommendations. The median time from initial submission to The BMJ to publication was 12 months. Only about one sixth explicitly disclosed registration deficiencies on publication. Of 72 authors responding about prospective registration on submission, 60 (83%) incorrectly claimed adherence. CONCLUSIONS: Many trials rejected by The BMJ for non-prospective registration in an ICMJE accepted registry were later published in high impact journals claiming adherence to the ICMJE recommendations, often without disclosure of registration deficiencies.
引用
- Blanco D, Loder E, Cook S, et al. Analysis of non-prospective trial registration in clinical trials submitted to The BMJ: observational study. BMJ. 2026. PMID: 41708134. doi:10.1136/bmj-2025-086467
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。